Negative HER-2 by Immunohistochemistry Correlates Strongly with Negative HER-2 Amplification by Fluorescence In Situ Hybridization in Triple Negative Breast Cancers

被引：0
|
作者：
Xian, R. [1 ]
Raghunath, P. [1 ]
Paul, Z. [1 ]
机构：
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
307
引用
收藏
页码：75A / 76A
页数：2
相关论文
共 50 条
  • [21] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization
    Shanmugalingam, Aswin
    Hitos, Kerry
    Pathmanathan, Nirmala
    Edirimmane, Senarath
    Hughes, T. Michael
    Ngui, Nicholas K.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (01) : 143 - 148
  • [22] Detection of HER-2/neu gene amplification by fluorescence in situ hybridization in human breast cancer
    Coupier, I
    Llorca, FP
    Perissel, B
    Tchirkov, A
    Malet, P
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 120 - 120
  • [23] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization
    Aswin Shanmugalingam
    Kerry Hitos
    Nirmala Pathmanathan
    Senarath Edirimmane
    T. Michael Hughes
    Nicholas K. Ngui
    Breast Cancer Research and Treatment, 2023, 198 : 143 - 148
  • [24] In Situ Hybridization Analysis of Invasive Breast Carcinomas with Immunohistochemically Negative Her-2 Status (A National Multicenter Study)
    Tuzlali, Sitki
    Yavuz, Ekrem
    Canda, Tulay
    Guray, Merih
    Ozgun Gecer, Melin
    Sullu, Yurdanur
    Sezer, Cem
    Suren, Dinc
    Dizbay Sak, Serpil
    Calay, Zerrin
    Ilvan, Sennur
    Zorludemir, Suzan
    Ergin, Melek
    Seyda Karaveli, Fatma
    Pestereli, Elif
    Ozdener, Fatih
    Ustundag, Kasim
    TURKISH JOURNAL OF PATHOLOGY, 2014, 30 (02) : 87 - 93
  • [25] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Sui, Weiguo
    Ou, Minglin
    Chen, Jiejing
    Wan, Youhua
    Peng, Hongbo
    Qi, Minfang
    Huang, He
    Dai, Yong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7 : 83
  • [26] Correlation of Her-2/neu results by immunohistochemistry and fluorescence in situ hybridization with survival in breast cancer.
    Kakar, S
    Puangsuvan, N
    Mihalov, ML
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) : 656 - 656
  • [27] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Weiguo Sui
    Minglin Ou
    Jiejing Chen
    Youhua Wan
    Hongbo Peng
    Minfang Qi
    He Huang
    Yong Dai
    World Journal of Surgical Oncology, 7
  • [28] Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis
    Xun, Xueqiong
    Ai, Jun
    Feng, Fuhui
    Hong, Pan
    Rai, Saroj
    Liu, Ruikang
    Zhang, Baowen
    Zhou, Yeming
    Hu, Huiyong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [29] HER-2/neu overexpression:: immunohistochemistry (IHC) or fluorescence in-situ hybridization (FISH)?
    Bunis, JA
    Weaver, DL
    Wells, WA
    Cole, BF
    Memoli, V
    Cates, J
    Schwartz, G
    Muss, HB
    Kaufman, PA
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S142 - S142
  • [30] Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification
    Ram, TG
    Schelling, ME
    Hosick, HL
    CELL GROWTH & DIFFERENTIATION, 2000, 11 (03): : 173 - 183
12345